Business Description
Fulgent Genetics Inc
NAICS : 621511
SIC : 8071
ISIN : US3596641098
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.81 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.31 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.54 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17.9 | |||||
3-Year FCF Growth Rate | -66.8 | |||||
3-Year Book Growth Rate | 23.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.64 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.52 | |||||
9-Day RSI | 44.87 | |||||
14-Day RSI | 41.74 | |||||
6-1 Month Momentum % | -17.12 | |||||
12-1 Month Momentum % | -27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.96 | |||||
Quick Ratio | 6.88 | |||||
Cash Ratio | 5.81 | |||||
Days Inventory | 9.97 | |||||
Days Sales Outstanding | 58.44 | |||||
Days Payable | 38.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 2.35 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.12 | |||||
Operating Margin % | -26.03 | |||||
Net Margin % | -58.03 | |||||
FCF Margin % | 1.61 | |||||
ROE % | -13.57 | |||||
ROA % | -12.5 | |||||
ROIC % | -9.18 | |||||
ROC (Joel Greenblatt) % | -78.88 | |||||
ROCE % | -5.94 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 8.4 | |||||
PS Ratio | 2.13 | |||||
PB Ratio | 0.54 | |||||
Price-to-Tangible-Book | 0.63 | |||||
Price-to-Free-Cash-Flow | 132.31 | |||||
Price-to-Operating-Cash-Flow | 22.88 | |||||
EV-to-EBIT | -2.8 | |||||
EV-to-Forward-EBIT | -3.7 | |||||
EV-to-EBITDA | -4.28 | |||||
EV-to-Forward-EBITDA | -5.59 | |||||
EV-to-Revenue | 0.73 | |||||
EV-to-Forward-Revenue | 0.74 | |||||
EV-to-FCF | 43.42 | |||||
Price-to-Projected-FCF | 0.21 | |||||
Price-to-Net-Current-Asset-Value | 1.51 | |||||
Price-to-Net-Cash | 1.89 | |||||
Earnings Yield (Greenblatt) % | -35.75 | |||||
FCF Yield % | 0.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fulgent Genetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 268.434 | ||
EPS (TTM) (€) | -5.192 | ||
Beta | 0.68 | ||
Volatility % | 53.61 | ||
14-Day RSI | 41.74 | ||
14-Day ATR (€) | 0.253376 | ||
20-Day SMA (€) | 19.434 | ||
12-1 Month Momentum % | -27 | ||
52-Week Range (€) | 18.6 - 37.5 | ||
Shares Outstanding (Mil) | 29.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fulgent Genetics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fulgent Genetics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Fulgent Genetics Inc Frequently Asked Questions
What is Fulgent Genetics Inc(FRA:7F0)'s stock price today?
When is next earnings date of Fulgent Genetics Inc(FRA:7F0)?
Does Fulgent Genetics Inc(FRA:7F0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |